Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Daisuke Sanada"'
Autor:
Ken Iseri, Masayuki Iyoda, Makoto Watanabe, Kei Matsumoto, Daisuke Sanada, Takashi Inoue, Shohei Tachibana, Takanori Shibata
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193846 (2018)
The clinical utility of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) has yet to be established. This study aimed to compare the effects of denosumab on bone mineral density (BMD) and bone turnover markers to those of alen
Externí odkaz:
https://doaj.org/article/2ccc1405f2344bcfad175a9e18bfd080
Autor:
Hirokazu Honda, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Go Takahashi, Nozomu Hosaka, Misa Ikeda, Daisuke Sanada, Takanori Shibata
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0176984 (2017)
A recent study demonstrated the association between inflammation, iron metabolism and fibroblast growth factor (FGF) 23. The present clinical study aimed to assess associations between anemia, iron metabolism and FGF23 in hemodialysis (HD) patients.
Externí odkaz:
https://doaj.org/article/61a5531b7a72499f805cd1d7df914eb5
Autor:
Hirokazu Honda, Tsutomu Hirano, Masashi Ueda, Shiho Kojima, Shinichi Mashiba, Yasuyuki Hayase, Tetsuo Michihata, Kanji Shishido, Keiko Takahashi, Nozomu Hosaka, Misa Ikeda, Daisuke Sanada, Takanori Shibata
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177980 (2017)
Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL,
Externí odkaz:
https://doaj.org/article/d357b0e9327c40dd82114d43fd55f505
Autor:
Kei Matsumoto, Makoto Watanabe, Takanori Shibata, Ken Iseri, Takashi Inoue, Daisuke Sanada, Masayuki Iyoda, Shohei Tachibana
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193846 (2018)
PLoS ONE
PLoS ONE
Introduction The clinical utility of denosumab for the treatment of glucocorticoid-induced osteoporosis (GIOP) has yet to be established. This study aimed to compare the effects of denosumab on bone mineral density (BMD) and bone turnover markers to
Autor:
Misa Ikeda, Daisuke Sanada, Kanji Shishido, Keiko Takahashi, Takanori Shibata, Tetsuo Michihata, Hirokazu Honda, Go Takahashi, Nozomu Hosaka
Publikováno v:
PLoS ONE
PLoS ONE, Vol 12, Iss 5, p e0176984 (2017)
PLoS ONE, Vol 12, Iss 5, p e0176984 (2017)
A recent study demonstrated the association between inflammation, iron metabolism and fibroblast growth factor (FGF) 23. The present clinical study aimed to assess associations between anemia, iron metabolism and FGF23 in hemodialysis (HD) patients.
Autor:
Keiko Takahashi, Takanori Shibata, Kanji Shishido, Tetsuo Michihata, Masashi Ueda, Hirokazu Honda, Daisuke Sanada, Shinichi Mashiba, Yasuyuki Hayase, Shiho Kojima, Nozomu Hosaka, Tsutomu Hirano, Misa Ikeda
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0177980 (2017)
PLoS ONE
PLoS ONE
Apolipoproteins are associated with survival among patients on hemodialysis (HD), but these associations might be influenced by dysfunctional (oxidized) high-density lipoprotein (HDL). We assessed associations among apolipoproteins and oxidized HDL,
Publikováno v:
Nephron Extra, Vol 2, Iss 1, Pp 233-246 (2012)
Background and Objectives: Erythropoiesis-stimulating agents (ESAs) might moderate circulating CD34-positive hematopoietic stem (CD34+) cells. We assessed associations between ESA therapy and CD34+ cells and their impact on cardiovascular disease (CV
Autor:
Masahiko Murakami, Takanori Shibata, Noriko Nunota, Yutaka Yamaguchi, Akio Yokochi, Tadao Akizawa, Noriyuki Kato, Tetsuzo Sugisaki, Daisuke Sanada, Hirokazu Honda, Aki Kuroki, Kazuho Honda, Osamu Yoshitake
Publikováno v:
CEN Case Reports. 1:12-15
We describe a middle-aged woman in whom granulomatous interstitial nephritis (GIN) developed in a renal allograft. She had undergone bowel resection due to an uncertain diagnosis of active granulomatous bowel disease 30 years earlier. Thereafter, fre
Autor:
Eijin Ashikaga, Nozomu Hosaka, Tadao Akizawa, Hiroki Suzuki, Daisuke Sanada, Kanji Shishido, Yuki Hirai, Noriyuki Kato, Mari Nakamura, Kei Matsumoto, Makoto Watanabe, Keiko Takahashi, Hirokazu Honda, Masanori Mukai, Hisako Nagai
Publikováno v:
Therapeutic Apheresis and Dialysis. 14:315-322
Levels of fibroblast growth factor (FGF) 23, a phosphatonin, are frequently elevated in patients with end-stage renal disease (ESRD) who are on maintenance hemodialysis (MHD). However, the role of FGF23 remains unclear because renal FGF receptor func
Autor:
Yuki Hirai, Daisuke Sanada, Nozomu Hosaka, Tadao Akizawa, Yumie Aoshima, Takanori Shibata, Masayuki Iyoda, Yoshihiro Kuno
Publikováno v:
Internal Medicine. 49:1783-1786
A hemodialysis patient with tuberculous peritonitis with hypercalcemia and high serum soluble interleukin-2 receptor (sIL-2R) and CA-125 levels is reported. An 82-year-old woman who had been on hemodialysis therapy for 6 years was admitted to our hos